Carter Bankshares Toekomstige groei

Future criteriumcontroles 4/6

Carter Bankshares zal naar verwachting groeien in winst en omzet met respectievelijk 36.9% en 13.8% per jaar. De winst per aandeel zal naar verwachting groeien met 38.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.7% zijn.

Belangrijke informatie

36.9%

Groei van de winst

38.2%

Groei van de winst per aandeel

Banks winstgroei	10.5%
Inkomstengroei	13.8%
Toekomstig rendement op eigen vermogen	9.7%
Dekking van analisten	Low
Laatst bijgewerkt	14 Nov 2024

Recente toekomstige groei-updates

Recent updates

Analysts Just Made A Major Revision To Their Carter Bankshares, Inc. (NASDAQ:CARE) Revenue Forecasts

Aug 01

It Looks Like Carter Bankshares, Inc.'s (NASDAQ:CARE) CEO May Expect Their Salary To Be Put Under The Microscope

Jun 17

Would Shareholders Who Purchased Carter Bankshares' (NASDAQ:CARE) Stock Three Years Be Happy With The Share price Today?

Mar 05

How Much Are Carter Bankshares, Inc. (NASDAQ:CARE) Insiders Taking Off The Table?

Jan 28

Carter Bank inks agreement with Pendleton Community Bank

Jan 14

Carter Bank & Trust  EPS of -$2.19

Oct 29

Winst- en omzetgroeiprognoses

NasdaqGS:CARE - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	175	36	N/A	N/A	2
12/31/2025	164	80	N/A	N/A	2
12/31/2024	136	21	N/A	N/A	2
9/30/2024	129	14	27	33	N/A
6/30/2024	126	12	25	32	N/A
3/31/2024	124	13	33	42	N/A
12/31/2023	134	23	37	47	N/A
9/30/2023	154	41	52	62	N/A
6/30/2023	165	51	64	74	N/A
3/31/2023	170	56	74	81	N/A
12/31/2022	158	50	65	71	N/A
9/30/2022	144	40	59	65	N/A
6/30/2022	137	37	73	81	N/A
3/31/2022	135	31	82	90	N/A
12/31/2021	136	31	69	78	N/A
9/30/2021	130	29	71	79	N/A
6/30/2021	124	-40	16	22	N/A
3/31/2021	117	-41	6	13	N/A
12/31/2020	113	-46	-2	8	N/A
9/30/2020	119	-45	-12	-2	N/A
6/30/2020	119	20	13	24	N/A
3/31/2020	123	23	4	15	N/A
12/31/2019	123	27	30	38	N/A
9/30/2019	122	26	32	43	N/A
6/30/2019	109	11	40	52	N/A
3/31/2019	109	11	39	53	N/A
12/31/2018	110	12	35	49	N/A
9/30/2018	93	3	36	49	N/A
6/30/2018	91	11	N/A	48	N/A
3/31/2018	76	2	N/A	43	N/A
12/31/2017	72	-1	N/A	44	N/A
9/30/2017	74	1	N/A	44	N/A
6/30/2017	83	6	N/A	34	N/A
3/31/2017	93	14	N/A	37	N/A
12/31/2016	96	16	N/A	33	N/A
9/30/2016	109	32	N/A	34	N/A
6/30/2016	113	36	N/A	38	N/A
3/31/2016	115	39	N/A	42	N/A
12/31/2015	115	39	N/A	54	N/A
9/30/2015	116	36	N/A	39	N/A
6/30/2015	115	35	N/A	40	N/A
3/31/2015	115	34	N/A	38	N/A
12/31/2014	113	33	N/A	44	N/A
9/30/2014	110	30	N/A	42	N/A
6/30/2014	109	29	N/A	43	N/A
3/31/2014	105	27	N/A	50	N/A
12/31/2013	105	26	N/A	37	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei CARE ( 36.9% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van CARE ( 36.9% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.4% per jaar).

Hoge groeiwinsten: De winst van CARE zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van CARE ( 13.8% per jaar) zal naar verwachting sneller groeien dan de markt US ( 9% per jaar).

Hoge groei-inkomsten: De omzet van CARE ( 13.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen CARE zal naar verwachting over 3 jaar laag zijn ( 9.7 %).

Carter Bankshares Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 18% to US$20.00

Price target decreased by 12% to US$15.00

Consensus EPS estimates increase by 155%

Consensus EPS estimates increase by 27%, revenue downgraded

Consensus EPS estimates increase by 151%

Price target decreased by 7.2% to US$15.25

Recent updates

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased by 18% to US$20.00

Second quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improves as stock rises 20%

Price target decreased by 12% to US$15.00

Consensus EPS estimates increase by 155%

Carter Bankshares, Inc., Annual General Meeting, May 22, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 27%, revenue downgraded

Carter Bankshares, Inc. Introduces Carter Zescrow

Consensus EPS estimates increase by 151%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.2% to US$15.25

Carter Bankshares, Inc. Reports Unaudited Net Charge Offs for the Third Quarter Ended September 30, 2023

Third quarter 2023 earnings: EPS misses analyst expectations

New major risk - Revenue and earnings growth

Consensus revenue estimates fall by 18%

Analysts Just Made A Major Revision To Their Carter Bankshares, Inc. (NASDAQ:CARE) Revenue Forecasts

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Insider selling

High number of new directors

Price target decreased by 8.4% to US$18.08

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorates as stock falls 21%

Carter Bankshares, Inc. Reports Net Charge-Offs for the Fourth Quarter Ended December 31, 2022

Full year 2022 earnings released: EPS: US$2.04 (vs US$1.19 in FY 2021)

Carter Bankshares, Inc. Announces Executive Changes

Price target increased to US$21.00

Third quarter 2022 earnings released: EPS: US$0.59 (vs US$0.42 in 3Q 2021)

Carter Bankshares, Inc. Reports Net Charge-Offs for the Third Quarter Ended September 30, 2022

Consensus EPS estimates increase by 16%

Second quarter 2022 earnings released: EPS: US$0.44 (vs US$0.20 in 2Q 2021)

Price target decreased to US$17.83

First quarter 2022 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

An unknown buyer acquired 16 Branches of Carter Bankshares, Inc.

Independent Director recently bought US$90k worth of stock

Price target increased to US$17.25

Third quarter 2021 earnings released: EPS US$0.42 (vs US$2.19 loss in 3Q 2020)

Price target increased to US$16.75

Second quarter 2021 earnings released: EPS US$0.21 (vs US$0.17 in 2Q 2020)

It Looks Like Carter Bankshares, Inc.'s (NASDAQ:CARE) CEO May Expect Their Salary To Be Put Under The Microscope

Price target increased to US$15.92

First quarter 2021 earnings released: EPS US$0.36 (vs US$0.17 in 1Q 2020)

Price target increased to US$14.58

Carter Bankshares, Inc. Announces Retirement of Charles E. Hall as Director

Carter Bankshares, Inc., Annual General Meeting, Jun 23, 2021

Revenue beats expectations

Full year 2020 earnings released: US$1.74 loss per share (vs US$1.01 profit in FY 2019)

Would Shareholders Who Purchased Carter Bankshares' (NASDAQ:CARE) Stock Three Years Be Happy With The Share price Today?

New 90-day high: US$12.05

Full year 2020 earnings released: US$1.74 loss per share (vs US$1.01 profit in FY 2019)

Revenue beats expectations

Farmers & Merchants Bank agreed to acquire operations of Branch Office in Waynesboro, Virginia of Carter Bankshares, Inc.

How Much Are Carter Bankshares, Inc. (NASDAQ:CARE) Insiders Taking Off The Table?

Price target raised to US$12.58

New 90-day high: US$12.02

Carter Bank inks agreement with Pendleton Community Bank

New 90-day high: US$11.00

New 90-day high: US$10.01

Price target raised to US$10.17

Analysts lower EPS estimates to -US$1.75

New 90-day high: US$7.95

Third quarter 2020 earnings released: US$2.19 loss per share

Revenue and earnings miss expectations

Carter Bank &amp; Trust&nbsp; EPS of -$2.19

New 90-day low: US$6.83

Carter Bank & Trust EPS of -$2.19